ArticleCancer medicine2023

Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation.

Kyunghye Bang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.